ConductScience.org, home

Trial · NCT06853574

Ventriculo-arterial Coupling and Myocardial Work in Sepsis and Septic Shock

NCT06853574, Not applicable, Not yet recruiting, General and Teaching Hospital Celje

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Ventriculo-arterial Coupling and Myocardial Work in Sepsis and Septic Shock. Trials, record NCT06853574. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06853574

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Ventriculo-arterial Coupling and Myocardial Work in Sepsis and Septic Shock
NCT number
NCT06853574
Status
Not yet recruiting
Phases
Not applicable
Enrollment
30 participants, estimated
Lead sponsor
General and Teaching Hospital Celje
Conditions
Sepsis, Septic Shock
Interventions
Fluid therapy, Noradrenaline infusion
First posted
2025-03-03
Last updated
2025-03-03

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChanges in ventriculo-arterial couplingFrom enrollment to 24 hours after treatment start
ventricular coupling will be analyzed on admission and its changes after treatment will be observed. To analyze ventriculo-arterial coupling, invasive blood pressure through either a radial or femoral arterial line will be collected and then data will be plotted into iElastance app available on smartphones to get the also knows as single beat determination ventriculo-arterial coupling.
PrimaryChanges in myocardial workFrom enrollment to 24 hours after treatment start
Myocardial work will be analyzed on admission and its changes after treatment will be observed. To realize this, a transthoracic cardiac ultrasound will be performed and the images will be transferred to EchoPAC from General Electrics (GE) to get the pressure-volume strain analysis also known as myocardial work.
SecondaryMean arterial pressure optimal targetFrom enrollment to 24 hours after treatment start
The study aims to identify the optimal mean arterial pressure (MAP) target in sepsis and septic shock with the combined evaluation of myocardial work and ventriculo-arterial coupling. To realize this, invasive blood pressure through either a radial or femoral arterial line will be collected and then data will be plotted into iElastance app available on smartphones to get the also knows as single beat determination ventriculo-arterial coupling.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers12

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
6507965BACKGROUNDPubMed
11738311BACKGROUNDPubMed
24108526BACKGROUNDPubMed
27451411BACKGROUNDPubMed
28465893BACKGROUNDPubMed
32243865BACKGROUNDPubMed
33596822BACKGROUNDPubMed
34806325BACKGROUNDPubMed
35062874BACKGROUNDPubMed
35170043BACKGROUNDPubMed

1 to 10 of 12

See all 12 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06853574

GET https://conductscience.org/api/trials/v1/NCT06853574/registered